It comes after a campaigner took a suitcase full of case studies to a high level meeting with four health chiefs from Spain’s top medication governing body on July 6.
Cristina Garcia del Campo, who has been tirelessly investigating Nolotil for the last seven months, said officials from the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) were ‘really receptive’.
“They are definitely going to stop it for people from this descent. They need to decide the best way to do it,” said Garcia del Campo.
It comes after the Olive Press launched its Kill the Drug campaign last year in a bid to bring in legislation.
AEMPS failed to comment in time for press.